Αρχική World News COVID-19, Cancer, and Uncertainty: An Oncologist’s Perspective on Coping

COVID-19, Cancer, and Uncertainty: An Oncologist’s Perspective on Coping

Anthony F. Provenzano, MD, is a practicing medical oncologist at New York-Presbyterian Lawrence Hospital located in Bronxville, New York. He received his medical degree from Cornell University Medical College and has been in practice since 1981. Dr. Provenzano is a member of the American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Committee and is also a member of the Cancer.Net Editorial Board.

The COVID-19 pandemic has resulted in uncertain times. It has affected people in many ways, leading to fear, confusion, anxiety, and, in some cases, depression. And people with cancer have been particularly susceptible to these effects. As an oncologist in New York, I share those feelings. I’ve had to deal with shifting and conflicting directions from  government and public health officials, who were just as blindsided by the pandemic. This has been a roller coaster health care crisis that we were all ill-prepared to handle. Like a tsunami, this pandemic hit us all—both patients and health care providers alike. As frontline first responders and other health care workers tried to sort things out, we were left standing on the shore looking inland, realizing that the damage had already begun.

Some of my patients developed COVID-19 while they were in the middle of life-saving cancer treatments, be it chemotherapy, radiation therapy, or immunotherapy. Thankfully, all of my patients recovered, and some of them were able to resume their planned cancer treatment. Others could only resume part of their treatment, had to modify their treatments, or had to stop treatment entirely.

Coordinating care during the pandemic has been—and still is—challenging. But I am thankful for the technology that has allowed us to continue to deliver care to our patients. The accelerated use and acceptance of telehealth visits has allowed me to video chat or chat over the phone with patients who I couldn’t see in person during the height of the pandemic. Eventually, as doctors were allowed to see patients in their offices and clinics, we combined virtual visits with in-person visits. This combination of treatment has allowed us to lower the risk of COVID-19 while still ensuring the health of our patients. I believe virtual visits are here to stay, and the pandemic just sped up the process of allowing us to experience the benefits of this technology.

In the early part of the pandemic, I participated in an ASCO webinar focused on developing new guidelines on how treatment would have to change for people with preexisting cancer or newly diagnosed cancer during this health crisis. These changes tried to adapt to the rapidly moving target of a virus that was unprecedented both in the United States and worldwide. Our recommendations depended on whether we were in a pre-surge, early surge, or peak surge of the novel coronavirus. These guidelines were an attempt to put some order into the way we would address COVID-19 and cancer.  For the oncologists making these decisions, we depended on our past experiences and our expertise in treating cancer, but these were new frontiers for even the best experts in the field. We are still in a time of uncertainty. We have yet to learn what the long-term outcomes of these actions and COVID-19 will be, and we are always learning new things about this virus.

I’ve seen many people with cancer who have been shell-shocked by the pandemic and who have been afraid to go to visits and follow up with their oncologists, even after public health officials gave them permission. Now, as we continue to learn how to navigate the pandemic, many people fear resuming normal follow-up visits for cancer surveillance and cancer screening. It is important that we continue these activities, even during the pandemic, because early detection can lead to more successful cancer treatment. These concerns about COVID-19 are normal and understandable. Discuss your fears and anxieties with your oncologist or other doctors, so your questions can be answered and your care can continue in the safest possible way.

As the COVID-19 pandemic continues, know that there are resources to help you cope. You can make use of online and in-person mental health resources. Nowadays online therapy is an option for mental health support. The Centers for Disease Control and Prevention (CDC) website, offers advice on how you, your family, and your community can cope with stress during the pandemic, including stress from the loss of a job, changes in sleep, worsening of mental health, and increased use of alcohol or other substances. Cancer.Net has extensive resources discussing how COVID-19 impacts people with cancer and survivors. Be sure to talk with your health care team about what other resources may be available to you during the pandemic.

The COVID-19 tsunami has hit, but I hope that the lessons we learn now will better prepare us for future public health crises like this one.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

2021 ASCO Annual Meeting Research Round Up: Advances in Treating Lung Cancer, Breast Cancer, and Sarcoma

In the annual Research Round Up series, Cancer.Net Associate Editors answer the question, “What was the most exciting or practice-changing research in your field...

Avapritinib Not Superior to Regorafenib in Terms of Median PFS in Third-Line or Later Treatment of Patients with Unresectable or Metastatic GIST

Findings from an open-label, randomised, multicentre phase III VOYAGER study indicate that avapritinib is not superior to regorafenib in terms of median progression-free survival...

Patients less likely to rate cancer care as ‘very good’ during pandemic

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Whilst...

How to Avoid Spreading Harmful Chemo Chemicals to Members of Your Household

Cancer is not contagious, and neither is chemotherapy. However, harmful chemotherapy drugs can sometimes still be present in the bodily fluids of a person...

The right combination for early detection

The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field. Here...

Can’t Sleep? Tips for Coping with Insomnia

Insomnia* is common for cancer patients**, as well as for the general population. We frequently hear from our patients and their caregivers that sleeping through the night...